Immupharma PLC Holding(s) in Company (3784H)
November 30 2015 - 6:55AM
UK Regulatory
TIDMIMM
RNS Number : 3784H
Immupharma PLC
30 November 2015
FOR IMMEDIATE RELEASE 30 NOVEMBER 2015
TR-1 NOTIFICATION OF MAJOR INTEREST IN SHARES BY AVIVA
ImmuPharma PLC (LSE:IMM), ("ImmuPharma" or the "Company"), the
specialist drug discovery and development company, confirms that it
has received a TR-1 by Aviva plc, providing an update on its direct
and indirect share allocation via its subsidiaries. The total
holding remains the same at 8,140,848 Ordinary Shares or 9.19% of
the issued share capital. Aviva is one of the largest institutional
shareholders in ImmuPharma.
The full TR-1 disclosure can be seen below.
For further information please contact:
+ 44 (0) 20
ImmuPharma plc 7152 4080
Tim McCarthy, Chairman
Lisa Baderoon, Head of Investor + 44 (0) 7721
Relations 413496
Panmure, Gordon & Co., NOMAD & +44 (0) 20 7886
Broker 2500
Fred Walsh, Duncan Monteith, Corporate
Finance
Charles Leigh-Pemberton, Corporate
Broking
TR-1 : MAJOR INTEREST IN SHARES
1. Identity of the issuer or Immupharma plc
the underlying issuer
of existing shares to which
voting rights are
attached: (ii)
------------------------------------------------------------- -------------------------------------------
2 Reason for the notification (please tick the appropriate
box or boxes):
----------------------------------------------------------------------------------------------------------
An acquisition or disposal of voting rights
------------------------------------------------------------------------------------------------------
An acquisition or disposal of qualifying financial
instruments which may result in the acquisition
of shares already issued to which voting rights
are attached
------------------------------------------------------------------------------------------------------
An acquisition or disposal of instruments with
similar economic effect to qualifying financial
instruments
------------------------------------------------------------------------------------------------------
An event changing the breakdown of voting rights
------------------------------------------------------------------------------------------------------
Other (please NOTIFICATION PROMPTED BY THE REMOVAL x
specify): OF STOCK LENDING EXEMPTION FOLLOWING
IMPLEMENTATION OF THE EU TRANSPARENCY
DIRECTIVE AMENDMENTS
--------------------------------------------------------- -------------------------------------------
3. Full name of person(s) Aviva plc & its subsidiaries
subject to the
notification obligation:
(iii)
----------------------------------------------------------- ---------------------------------------------
4. Full name of shareholder(s) Registered Holder:
(if different from 3.):(iv)
BNY Norwich Union Nominees
Limited 232,080*
Chase (GA Group) Nominees
Limited 6,809,654*
*denotes direct interest
Chase (GA Group) Nominees
Limited 373,991
Chase Nominees Limited 150,841
Vidacos Nominees Limited 406,282
----------------------------------------------------------- ---------------------------------------------
5. Date of the transaction 25 November 2015
and date on
which the threshold is
crossed or
reached: (v)
----------------------------------------------------------- ---------------------------------------------
6. Date on which issuer 27 November 2015
notified:
----------------------------------------------------------- ---------------------------------------------
7. Threshold(s) that is/are 8% to 7% Change at Direct
crossed or Interest Level
reached: (vi, vii)
----------------------------------------------------------- ---------------------------------------------
8. Notified details:
-----------------------------------------------------------------------------------------------------------
A: Voting rights attached to shares (viii, ix)
-----------------------------------------------------------------------------------------------------------
Class/type Situation previous Resulting situation after
of to the triggering the triggering transaction
shares transaction
if possible
using
the ISIN
CODE
------------------- ------------------------------- -----------------------------------------------------
Number Number Number Number of % of voting
of of of voting rights (x)
Shares Voting shares rights
Rights
------------------- ------------------- ---------- ---------- --------------------- ------------------
Direct Direct Indirect Direct Indirect
(xi) (xii)
------------------- ------------------- ---------- ---------- ---------- --------- ------- ---------
Ordinary
Shares
GB0033711010 8,143,876 8,143,876 7,972,848 7,041,734 931,114 7.95% 1.05%
------------------- ---------- ---------- ---------- --------- ------- ---------
B: Qualifying Financial Instruments
-----------------------------------------------------------------------------------------------------------
Resulting situation after the triggering transaction
-----------------------------------------------------------------------------------------------------------
Type of financial Expiration Exercise/ Number of voting % of voting
instrument date Conversion rights that rights
(xiii) Period (xiv) may be
acquired if
the
instrument
is
exercised/
converted.
------------------- ------------------- ---------------------- --------------------- ------------------
C: Financial Instruments with similar economic effect
to Qualifying Financial Instruments (xv, xvi)
----------------------------------------------------------------------------------------------------
Resulting situation after the triggering transaction
----------------------------------------------------------------------------------------------------
Type of financial Exercise Expiration Exercise/ Number of voting % of voting
instrument price date Conversion rights instrument rights (xix,
(xvii) period refers to xx)
(xviii)
------------------- ---------- ------------ ------------- -------------------- ----------------
RIGHT TO N/A N/A N/A Nominal Delta
RECALL LOANED
SHARES
------------------- ---------- ------------ ------------- -------------------- -------- ------
168,000 *
* Direct interest 0.19%
------------------------------------------------------------------------------ -------- ------
Total (A+B+C)
------------------------------------------------------
Number of voting rights Percentage of voting rights
------------------------ ----------------------------
8,140,848 9.19%
------------------------ ----------------------------
9. Chain of controlled undertakings through which the
voting rights and/or the
financial instruments are effectively held, if applicable:
(xxi)
---------------------------------------------------------------------------------
The voting rights are managed and controlled by Aviva
Investors Global Services Limited, with the following
chain of controlled undertakings:-
Aviva Investors Global Services Limited:
* Aviva plc (Parent Company)
(MORE TO FOLLOW) Dow Jones Newswires
November 30, 2015 06:55 ET (11:55 GMT)
Immupharma (LSE:IMM)
Historical Stock Chart
From Jun 2024 to Jul 2024
Immupharma (LSE:IMM)
Historical Stock Chart
From Jul 2023 to Jul 2024
